Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
United States
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio